Press release
Acute Bacterial Prostatitis (ABP) market is expected to reach USD 2.35 billion by 2034
Acute bacterial prostatitis (ABP) is a sudden, severe infection of the prostate gland caused mainly by Gram-negative bacteria such as Escherichia coli, Proteus, Klebsiella, and sometimes Pseudomonas. It presents with fever, pelvic pain, urinary tract symptoms, and systemic illness, often requiring urgent medical attention.Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71755
Although less common than chronic prostatitis, ABP is clinically significant due to the risk of sepsis, urinary retention, and abscess formation. Treatment relies heavily on broad-spectrum antibiotics, hospitalization in severe cases, and supportive care. Rising diagnostic advancements and improved awareness among healthcare providers are expanding the market outlook.
Market Overview
• Market Size (2024): USD 1.35 billion
• Forecast (2034): USD 2.35 billion
• CAGR (2025-2034): 5.6%
Growth is fueled by high incidence of urinary tract infections (UTIs), expanding antibiotic pipelines, and improved diagnostic protocols in urology.
Key Highlights:
• ABP is often underdiagnosed, but accounts for ~10% of all prostatitis cases.
• Fluoroquinolones and cephalosporins remain standard therapies, but resistance is rising.
• Expanding use of molecular urine cultures and imaging for rapid diagnosis.
• Increasing hospital admissions for severe cases driving antibiotic demand.
Segmentation Analysis
By Product Type:
• Antibiotics
o Fluoroquinolones (ciprofloxacin, levofloxacin)
o Cephalosporins (ceftriaxone, ceftazidime)
o Beta-Lactams (ampicillin, piperacillin-tazobactam)
o Carbapenems (imipenem, meropenem - for resistant cases)
o Aminoglycosides (gentamicin, amikacin)
• Adjunctive Therapies
o Alpha-Blockers (to improve urinary flow)
o Analgesics & Anti-Inflammatories
• Diagnostics
o Urine Culture & Sensitivity Testing
o PCR-Based Bacterial Testing
o Imaging (ultrasound, CT, MRI for abscesses)
• Supportive Care
o Catheterization in urinary retention
o IV fluids and hospitalization
By Platform:
• Small Molecule Antibiotics
• Biologics (emerging research in monoclonals)
• Diagnostics
By Technology:
• Molecular Diagnostics (PCR, NAATs)
• AI-Driven Imaging for Prostate Infections
• Advanced Culture Systems
By End Use:
• Hospitals & ICUs
• Urology Clinics
• Diagnostic Laboratories
• Outpatient Clinics
By Application:
• Gram-Negative ABP (most common)
• Gram-Positive ABP (less common, e.g., Enterococcus)
• Resistant & Complicated ABP
• Clinical Research
Segmentation Summary:
Antibiotics dominate treatment, with fluoroquinolones and cephalosporins widely prescribed. Molecular diagnostics and imaging are growing rapidly for complicated and resistant cases. Hospitals remain the largest end-use segment.
Explore Full Report here:https://exactitudeconsultancy.com/reports/71755/acute-bacterial-prostatitis-market
Regional Analysis
North America
• ~38% share in 2024.
• High diagnosis and treatment rates.
• Strong stewardship programs but growing resistance concerns.
Europe
• ~29% share.
• Germany, UK, and France leading in adoption of new diagnostics.
• EMA approvals of advanced antibiotics boosting growth.
Asia-Pacific
• Fastest-growing region with CAGR of ~6.8%.
• Rising incidence of UTIs and prostatitis in India and China.
• Expanding hospital infrastructure and antibiotic access.
Middle East & Africa
• Smaller market share with significant unmet needs.
• Limited diagnostic access in rural settings.
Latin America
• Brazil and Mexico driving regional demand.
• Increasing access to generic antibiotics.
Regional Summary:
North America and Europe dominate due to advanced healthcare infrastructure, while Asia-Pacific grows fastest due to higher infection burden and healthcare expansion.
Market Dynamics
Key Growth Drivers:
• Rising incidence of ABP linked to UTIs and urinary retention.
• Expanding antibiotic development pipelines.
• Growing use of molecular diagnostics for rapid bacterial detection.
• Increasing hospitalization rates for severe ABP cases.
Key Challenges:
• Rising resistance to fluoroquinolones and cephalosporins.
• Underdiagnosis due to overlap with other urological disorders.
• High treatment costs for resistant infections.
• Limited diagnostic access in low-income countries.
Latest Trends:
• Combination antibiotic therapies for resistant infections.
• AI-assisted prostate imaging for complicated ABP.
• Stewardship programs ensuring rational antibiotic use.
• Tele-urology expanding outpatient diagnosis and follow-up.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71755
Competitor Analysis
Major Players in the Market:
• Pfizer Inc.
• Merck & Co., Inc.
• GlaxoSmithKline plc
• Novartis AG
• Johnson & Johnson
• Cipla Ltd.
• Dr. Reddy's Laboratories Ltd.
• Lupin Limited
• Abbott Laboratories (diagnostics)
• Roche Diagnostics
Competitive Summary:
Pfizer, Merck, and J&J dominate antibiotics, while Cipla, Dr. Reddy's, and Lupin expand generic access. Roche and Abbott lead diagnostics. Competition is centered on new antibiotics, rapid diagnostics, and resistance management.
Conclusion
The Acute Bacterial Prostatitis (ABP) Market, valued at USD 1.35 billion in 2024, is projected to reach USD 2.35 billion by 2034, growing at a CAGR of 5.6%. Rising incidence, improved diagnostics, and antibiotic pipelines are shaping the market's future.
Key Takeaways:
• Antibiotics remain the gold standard, but resistance is a growing concern.
• North America and Europe dominate, while Asia-Pacific grows fastest.
• Diagnostics and AI-driven imaging improving detection and outcomes.
• Tele-urology and outpatient care expanding access.
The next decade will redefine ABP management with precision diagnostics, novel antibiotics, and telemedicine integration, creating opportunities for pharmaceutical innovators, diagnostics firms, and healthcare providers worldwide.
This report is also available in the following languages : Japanese (急性細菌性前立腺炎市場), Korean (급성 세균성 전립선염 시장), Chinese (急性细菌性前列腺炎市场), French (Marché de la prostatite bactérienne aiguë), German (Markt für akute bakterielle Prostatitis), and Italian (Mercato della prostatite batterica acuta), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/71755/acute-bacterial-prostatitis-market#request-a-sample
Our More Reports:
Nuclear Imaging Agents Market
https://exactitudeconsultancy.com/reports/72435/nuclear-imaging-agents-market
Quality Control and Regulation in Medical Devices Market
https://exactitudeconsultancy.com/reports/72434/quality-control-and-regulation-in-medical-devices-market
3D Bioprinting White Spaces Analysis Market
https://exactitudeconsultancy.com/reports/72433/3d-bioprinting-white-spaces-analysis-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Bacterial Prostatitis (ABP) market is expected to reach USD 2.35 billion by 2034 here
News-ID: 4179388 • Views: …
More Releases from Exactitude Consultancy

Cell Therapy Manufacturing Market to Reach USD 28.4 Billion by 2034, Growing at …
Introduction
Cell therapy has emerged as a transformative pillar of modern medicine, offering the potential to repair, replace, or regenerate damaged tissues and organs. From CAR-T cell therapies for oncology to stem cell therapies for regenerative medicine, the field is redefining treatment paradigms across oncology, neurology, cardiology, and rare diseases.
As clinical pipelines expand and more therapies achieve regulatory approval, demand for efficient and scalable cell therapy manufacturing has surged. Specialized technologies…

Despite safety concerns, adavosertib exhibits early antitumor activity in uterin …
Uterine serous carcinoma (USC) is a rare but highly aggressive subtype of endometrial cancer, accounting for less than 10% of endometrial cancer cases but contributing to a disproportionately high mortality rate. It is often diagnosed at advanced stages, making it difficult to treat with conventional methods.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72873
In recent years, the treatment landscape has expanded beyond chemotherapy and surgery to include targeted therapies,…

Market for Catheter-Related Bloodstream Infections: Overview, Therapies, and Imp …
Catheter-related bloodstream infections (CRBSIs) are among the most common and serious complications associated with intravascular catheters used in hospitals and long-term care settings. These infections can lead to prolonged hospital stays, increased healthcare costs, and higher mortality rates. With the rising use of central venous catheters, particularly among critically ill patients, oncology cases, and those requiring long-term intravenous therapy, the global demand for effective prevention and treatment solutions is growing…

ADC Technology Market to Reach USD 33.7 Billion by 2034, Growing at 13.2% CAGR
Introduction
Antibody-drug conjugates (ADCs) represent one of the most innovative breakthroughs in oncology, combining the target specificity of monoclonal antibodies with the cytotoxic potency of chemotherapeutic agents. By delivering highly toxic payloads directly to cancer cells, ADCs minimize systemic toxicity and enhance therapeutic efficacy.
As cancer incidence rises worldwide and the limitations of conventional chemotherapy become more evident, ADC technology is gaining momentum. With advancements in linker chemistry, payload design, and next-generation…
More Releases for ABP
Port Equipment Market to See Thriving Worldwide | Kalmar (Finland, Konecranes Ab …
HTF MI just released the Global Port Equipment Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Port Equipment Market are:
• Kalmar (Finland): A…
Marine Propeller Market is Thriving Worldwide | Nakashima Propeller, Mandiesel&t …
IMR Market Report recently introduced Marine Propeller Market study with 175+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence. Some key players from the complete study are Nakashima Propeller, Mandiesel&turbo, Wartsila Oyj Abp, Mitsubishi Heavy Industries, Hyundai Heavy Industries, Michigan…
Global 24-Hour ABP Monitors Market Analysis By Major Manufacturers and Competiti …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2024 latest report "24-Hour ABP Monitors- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030". Based on current situation and impact historical analysis (2019-2023) and forecast calculations (2024-2030), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.
24-hour ABP monitors are…
Polyester Adhesives Market | Dow Chemical Company, Axson Technologies, Evonik In …
The Polyester Adhesives report presents high-quality and wide-ranging research study with key factors that are expected to have a Major impact on the Polyester Adhesives during the forecast period. The report present Key Market segments valued based on its growth rate and share.This report also provides an analysis of the impact of the COVID-19 pandemic on Industrial Labels Industry.The report explains the historical and current trends that are shaping…
PCB Board Market 2017- Dongguan HRSC PCB, HTD, ABP Electronics, Advanced Circuit …
A market study ” Global PCB Board Market ” examines the performance of the PCB Board market 2017. It encloses an in-depth Research of the PCB Board market state and the competitive landscape globally. This report analyzes the potential of PCB Board market in the present and the future prospects from various angles in detail.
The Global PCB Board Market 2017 report includes PCB Board market Revenue, market Share, PCB Board…
ABP News Network gives the creative communications mandate to Macaw Communicatio …
New Delhi: The communication and advertising venture of INCL Group, Macaw Communication & Advertisements Pvt. Ltd. won the creative communications mandate for ABP Asmita, the regional channel for Gujarat state in a multi-agency pitch. The agency won this pitch due to the multi-industry experience of more than two decades and expertise in the related electronic media sector.
Sharing his views on this account win, Mr. Prashant Kumar, Director & CEO,…